Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

16. Mai 2016 09:00 ET | Quelle: Endologix

Endologix Completes Patient Enrollment in the Ovation® LIFE (Least Invasive Fast-Track EVAR) Study

IRVINE, Calif., May 16, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient...
09. Mai 2016 16:05 ET | Quelle: Endologix

Endologix Reports Results for the First Quarter 2016

IRVINE, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the...
29. April 2016 09:00 ET | Quelle: Endologix

Endologix to Participate in Two Investor Conferences in May

IRVINE, Calif., April 29, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief...
28. April 2016 12:15 ET | Quelle: Endologix

Positive Nellix Clinical Data from the ASCEND Study for the Treatment of Juxta and Pararenal AAA Presented at the 38th Annual Charing Cross Symposium

IRVINE, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the first data presentation...
27. April 2016 11:00 ET | Quelle: Endologix

Positive Nellix Clinical Data from the Global Registry and Treatment of Iliac Aneurysm Studies Presented at the 38th Annual Charing Cross Symposium

IRVINE, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of positive...
19. April 2016 16:00 ET | Quelle: Endologix

Endologix to Report First Quarter 2016 Financial Results on May 9, 2016

IRVINE, Calif., April 19, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details relating to the...
11. April 2016 14:25 ET | Quelle: Endologix

Endologix Announces CE Mark for Next-Generation Nellix® EndoVascular Aneurysm Sealing System

IRVINE, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today achievement of CE...
08. März 2016 09:00 ET | Quelle: Endologix

Endologix Announces First Patients in Japan Treated With Nellix® EndoVascular Aneurysm Sealing System

IRVINE, Calif., March 08, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that the first two patients...
29. Februar 2016 09:00 ET | Quelle: Endologix

Endologix Announces First U.S. Commercial Implant of AFX®2 Bifurcated Endograft System

IRVINE, Calif., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that the first U.S....
22. Februar 2016 16:05 ET | Quelle: Endologix

Endologix Reports Results for the Fourth Quarter and Full Year 2015

8% Constant Currency Revenue Growth for the Full Year 2015 2015 Nellix European Systems Increase 42% Over Prior Year Provides 2016 Financial Guidance for Combined Company...

Vorherige Seite

Nächste Seite